Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.

Dong, Ying; Chin, Shook-Fong; Blanco, Elvin; Bey, Erik A; Kabbani, Wareef; Xie, Xian-Jin; Bornmann, William G; Boothman, David A; Gao, Jinming

Dong, Ying; Chin, Shook-Fong; Blanco, Elvin; Bey, Erik A; Kabbani, Wareef; Xie, Xian-Jin; Bornmann, William G; Boothman, David A; Gao, Jinming.

Affiliation

Dong Y; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.

Clin Cancer Res ; 15(1): 131-9, 2009 Jan 01.

Article in En | MEDLINE | ID: mdl-19118040

Subject(s)

Antineoplastic Agents/therapeutic use; Drug Implants/administration & dosage; Naphthoquinones/administration & dosage; Prostatic Neoplasms/drug therapy; Animals; Antineoplastic Agents/administration & dosage; Cell Line, Tumor; Drug Carriers/administration & dosage; Drug Implants/therapeutic use; Humans; Male; Mice; Mice, Nude; Naphthoquinones/therapeutic use; Polymers/pharmacology; Prostatic Neoplasms/pathology; Xenograft Model Antitumor Assays

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Naphthoquinones / Drug Implants / Antineoplastic Agents Limits: Animals / Humans / Male Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2009 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google